19 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
Pharmacologic Treatment of Hyperthyroidism

#Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Pharmacologic Treatment ... Hyperthyroidism #Treatment ... #Management #Pharmacology ... #Medications #Comparison ... #Table #Endocrinology
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
formulations, comparison ... considerations #pharmacology ... #table #medications ... #comparison #drugs ... #treatment #pharmacotherapy
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... Tobacco Cessation Treatment ... ) #Pharmacology ... Cessation #Therapy #Comparison ... #Table #Agents
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... medical diagrams, tables ... NSAIDS #management #pharmacology ... #table #comparison ... #medications #treatment
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Medications approved ... the long-term treatment ... mg #Obesity #Medications ... WeightLoss #AACE #2016 #Pharmacology ... #Table #Comparison
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Guidelines # ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines ... #Treatment
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... endocrinology #treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Dosing: 250 mcg tablet ... recommendations for the treatment ... #Roflumilast #Indications ... #Pharmacology #
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... summarised in Tables ... EBM #Management #Pharmacology ... Personality #Disorder #Medications ... Effectiveness #Table